6533b7cffe1ef96bd1259a2a

RESEARCH PRODUCT

Sentinel Lymph Node Analysis in Colorectal Cancer Patients Using One-Step Nucleic Acid Amplification in Combination With Fluorescence and Indocyanine Green

Francesco EspositoIna MacaioneUmberto FerboFrancesco CrafaAntonio MiroAdele NovielloNicola MolesMario BaiamonteMaria LeporeEnrico Coppola Bottazzi

subject

medicine.medical_specialtyindocyanine greenAdjuvant chemotherapyColorectal cancermedicine.medical_treatmentSentinel lymph nodeH&E staincolorectal cancerRC799-86903 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicinesentinel lymph node analysisLymph nodebusiness.industryGastroenterologyDiseases of the digestive system. Gastroenterologymedicine.diseaseSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurechemistryone-step nucleic acid030220 oncology & carcinogenesisNucleic acidOriginal Article030211 gastroenterology & hepatologySurgeryLymphadenectomyfluorescenceRadiologySentinel lymph node analysibusinessIndocyanine green

description

Purpose: Analysis of the sentinel lymph node (SLN) in colorectal cancer (CRC) patients was proposed for more accurate staging and tailored lymphadenectomy. The aim of this study was to assess the ability to predict lymph node (LN) involvement through analysis of the SLN with a one-step nucleic acid (OSNA) technique in combination with peritumoral injection of indocyanine green (ICG) and near-infrared (NIR) lymphangiography in CRC patients. Methods: A total of 34 patients were enrolled. Overall, 51 LNs were analyzed with OSNA. LNs of 17 patients (50%) were examined simultaneously with hematoxylin and eosin (H&E) and OSNA. Results: SLN analysis of 17 patients examined with H&E and OSNA revealed that OSNA had a higher sensitivity (1 vs. 0.55), higher negative predictive value (1 vs. 0.66) and higher accuracy (100% vs. 76.4%) in predicting LN involvement. Overall, OSNA showed a sensitivity of 0.69, specificity of 1, accuracy of 88.2%, and stage migration of 8.8%. Compared to those who were OSNA (−), OSNA (+) patients had a greater number of LN metastases (4.8 vs. 0.16, P = 0.04), higher G3 rate (44.4% vs. 4%, P = 0.01), more advanced stage of disease (stage III: 77.8% vs. 16%; P = 0.00) and were more rapidly subjected to adjuvant chemotherapy (39.1 days vs. 50.2 days, P = 0.01). Conclusion: SLN analysis with OSNA in combination with ICG-NIR lymphangiography is feasible and can detect LN involvement in CRC patients. Furthermore, it allows for more accurate staging reducing the delay between surgery and adjuvant chemotherapy

https://doi.org/10.3393/ac.2018.07.21.1